acm-header
Sign In

Communications of the ACM

ACM Opinion

How AI Changes The Stakes For Pharma


AI drug development, illustration

Credit: Nvidia

In their never-ending quest to speed drug discovery, development, and commercialization, pharmaceutical and biotechnology companies are now turning to information technology's latest darling, artificial intelligence (AI). Top firms are diving deep. Smaller companies are also trying to become players.

But how can drug developers leverage AI to reverse the decline in R&D productivity that has persisted in the face of other IT technologies?

From Bio-IT World
View Full Article


 

No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account